FIELD: medicine.
SUBSTANCE: method involves administering Leuzea (Rhaponticum carthamoides) extract for treating spermatogenesis disorders.
EFFECT: enhanced effectiveness of treatment; low toxicity; reduced risk of adverse side effects.
3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF OXIDISED DEXTRAN FOR TREATING AND PREVENTING INFECTIOUS-INFLAMMATORY DISORDERS OF SPERMATOGENESIS | 2023 |
|
RU2814617C1 |
| METHOD FOR CORRECTION OF REMOTE CONSEQUENCES OF SPERMATOGENESIS CAUSED BY CYTOSTATIC EXPOSURE | 2013 |
|
RU2535002C2 |
| METHOD OF CORRECTING, CAUSED BY CYTOSTATIC IMPACT | 2009 |
|
RU2406527C1 |
| AGENT FOR PATHOZOOSPERMIA PREVENTION AND TREATMENT | 2016 |
|
RU2619330C1 |
| USE OF COMPLEX OF 9-PHENYL-2,3,4,5,6,7,8,9-OCTAHYDRO-1H-SELENOXANTHENE WITH β-CYCLODEXTRIN FOR CORRECTION OF SPERMATOGENESIS DISORDERS CAUSED BY CYTOTOXIC EFFECT | 2019 |
|
RU2782758C2 |
| AGENT FOR PREVENTING AND TREATING ASTHENOZOOSPERMIA AND TERATOZOOSPERMIA | 2020 |
|
RU2739491C1 |
| MEANS FOR CORRECTION OF PATHOLOGIC CHANGES OF VIABLE OFFSPRING, CAUSED BY CYTOSTATIC IMPACT ON MOTHER'S ORGANISM | 2014 |
|
RU2552612C1 |
| HEMORHEOLOGICAL AGENT AND METHOD OF ITS PREPARING | 1998 |
|
RU2191027C2 |
| STIMULATOR OF REPARATIVE REGENERATION PROCESSES OF TESTICULAR TISSUE | 2019 |
|
RU2778238C2 |
| REMEDY FOR DELAYED EFFECTS OF SPERMATOGENESIS DISORDERS CAUSED BY CYTOSTATIC EFFECT | 2019 |
|
RU2717240C1 |
